Searching across hundreds of databases
It is well established that fibrotic remodeling of the tumor microenvironment favors tumorigenesis, but whether fibrosis underlies malignant progression in other ways is unclear. Here, we report that adaptive myofibroblastic reprogramming of osteosarcoma stem cells (OSCs) results in a critical advantage when establishing lung macro-metastases and spheroid growth but does not affect the growth of primary lesions or monolayer cultures. FGFR2 signaling in OSCs initiates fibrosis, whereas the resultant fibronectin (FN) auto-deposition sustains fibrogenic reprogramming and OSC growth, resembling the process employed by non-malignant myofibroblasts to cause tissue fibrosis. Furthermore, we provide evidence that nintedanib targets the pan FGFR-FN axis to disrupt lung metastasis without affecting the bone lesion growth of OSCs. Thus, myofibroblastic reprogramming of human OSCs in the lungs might represent a druggable trait for treating a deadly metastatic complication.
Pubmed ID: 30067981 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Human Oct-3 / 4
View all literature mentionsThis polyclonal targets CDKN1B
View all literature mentionsThis monoclonal targets BrdU
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets S6 Ribosomal Protein (54D2) Mouse mAb
View all literature mentionsThis monoclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis monoclonal targets Akt2
View all literature mentionsThis polyclonal targets p70 S6 Kinase
View all literature mentionsThis monoclonal targets p21 Waf1/Cip1
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis monoclonal targets synthetic peptide corresponding to residues near the carboxy terminus of human Src.
View all literature mentionsThis polyclonal targets S100A4 antibody
View all literature mentionsThis monoclonal targets GFP
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Phospho-Smad3 (Ser423/425) (C25A9) Rabbit mAb
View all literature mentionsThis monoclonal targets Nanog (1E6C4) Mouse mAb
View all literature mentionsThis polyclonal targets Phospho-S6 Ribosomal Protein (Ser235/236)
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis monoclonal targets Phospho-Akt (Thr308) (C31E5E) Rabbit mAb
View all literature mentionsThis polyclonal targets Phospho-p70 S6 Kinase (Thr389)
View all literature mentionsThis monoclonal targets Stage-Specific Embryonic Antigen-4
View all literature mentionsThis monoclonal targets Human/Mouse SSEA-4 Phycoerythrin MAb (Cl MC-813-70)
View all literature mentionsThis polyclonal targets Fgfr4
View all literature mentionsThis monoclonal targets FGFR3
View all literature mentionsThis unknown targets FGF Receptor 1
View all literature mentionsThis monoclonal targets Fgfr3
View all literature mentionsThis unknown targets Cyclin E, phospho (Thr62)
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets CDK3
View all literature mentionsThis monoclonal targets Integrin beta 3 antibody [EPR2342]
View all literature mentionsThis polyclonal targets Integrin 3
View all literature mentionsThis monoclonal targets Actin, alpha, Smooth Muscle
View all literature mentionsThis monoclonal targets Vimentin (V9)
View all literature mentionsThis unknown targets Paxillin
View all literature mentionsThis polyclonal targets Phospho-Paxillin (Tyr118)
View all literature mentionsThis polyclonal targets Phospho-Src Family (Tyr416)
View all literature mentionsThis monoclonal targets Collagen Type I
View all literature mentionsThis polyclonal targets FN1
View all literature mentionsThis monoclonal targets SSEA-4
View all literature mentionsThis monoclonal targets BrdU
View all literature mentionsThis monoclonal targets Human Oct-3 / 4
View all literature mentionsThis monoclonal targets p21 Waf1/Cip1
View all literature mentionsThis polyclonal targets CDKN1B
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
